Adapalene/benzoyl peroxide - Galderma
Alternative Names: Adapalene/BPO; Benzoyl-peroxide/adapalene; BPO/adapalene; CD 0271/CD 1579; Epiduo; Epiduo Forte; GK-530G; Tactuo™; Tactupump; TactuPump ForteLatest Information Update: 29 Oct 2021
Price :
$50 *
At a glance
- Originator Galderma
- Class Anti-infectives; Anti-inflammatories; Antiacnes; Benzoic acids; Keratolytics; Naphthalenes; Oxidants; Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris
Most Recent Events
- 04 Mar 2021 No development reported - Phase-III for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in Singapore and Mauritius (Topical)
- 03 Apr 2019 Chemical structure information added
- 12 Oct 2016 Galderma plans the phase III EDeN trial for Acne vulgaris (Monotherapy, In adolescents, In adults) Brazil, Mauritius, Singapore and USA (IV) (NCT02932267)